Michael Ackermann, Director at Tarsus Pharmaceuticals, Inc. (TARS), sold 11,666 shares at $25.24 ($294K) on 2021-09-01, disclosed to the SEC on 2021-09-03.
Open-market sale of $294k TARS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.24 | 5,833 | $147K | 50.0% |
| 2 | $25.24 | 5,833 | $147K | 50.0% |
| Total | $25.24 avg | 11,666 | $294K | 100% |
| Filing → |
| TARS | SELL | 2021-11-03 | $300K | — | Filing → |
| TARS | SELL | 2021-10-14 | $267K | — | Filing → |
| TARS | SELL | 2021-10-12 | $5K | — | Filing → |